A
team developing anti-cancer and anti-inflammatory drugs from research based on
the immune systems of sharks has received a £1.5m funding boost.
The
University of Aberdeen has received the financial backing to develop man-made
proteins closely related to structures found in sharks.
Sharks
are one of the most ancient species on the planet.
Scottish
Enterprise and the Biotechnology and Biological Sciences Research Council
awarded the money.
Structures
called variable novel antigen receptors (VNARs) are found in the shark immune
system.
